StoneX Group’s Ampio Pharmaceuticals Inc. AMPE Stock Holding History

StoneX Group’s Portfolio AMPE Stock Details AMPE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-1,005	Closed	-$4.53K	–	899
2022 Q4	$4.53K	Buy	+1,005	New	+$6.48K	﹤0.01%	605

Other funds holding AMPE

HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return

CFO

CVA Family Office Denver, Colorado $1.1B AUM 26.6% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

BJL

Brighton Jones LLC Seattle, Washington $5.38B AUM 27.31% 1-Year Est. Return

WWM

Western Wealth Management Golden, Colorado $3.06B AUM 26.31% 1-Year Est. Return

Courier Capital Buffalo, New York $2B AUM 24.36% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

TSS

Two Sigma Securities New York $1.16B AUM 36.23% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

StoneX Group's AMPE Position: Q1 2023 in Review

StoneX Group sold out of Ampio Pharmaceuticals Inc. (AMPE) in Q1 2023, closing a stake of 1,005 shares — an estimated $4.53K sold.

StoneX Group first reported a position in AMPE in Q4 2022 and held it in 1 quarter. The position peaked at $4.53K in Q4 2022. 35 funds tracked by Wall St. Rank hold AMPE as of Q1 2023.

StoneX Group reported no remaining Ampio Pharmaceuticals Inc. position as of Q1 2023 after selling out during the quarter.
StoneX Group sold 1,005 Ampio Pharmaceuticals Inc. shares in Q1 2023, an estimated $4.53K.
StoneX Group first reported a position in Ampio Pharmaceuticals Inc. in Q4 2022 and held it in 1 quarter.
StoneX Group's Ampio Pharmaceuticals Inc. position peaked at $4.53K in Q4 2022.
35 funds tracked by Wall St. Rank held Ampio Pharmaceuticals Inc. as of Q1 2023.

Based on StoneX Group's 13F filing for Q1 2023, filed 11 May 2023.